The Role of MUC1 in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): The Correlation with Disease Severity

Rossana Giancaspro1, Giuseppe Stefano Netti2, Federica De Luca2

  • 1Unit of Otolaryngology, Department of Clinical and Experimental Medicine, University of Foggia, Via Luigi Pinto 1, 71122 Foggia, Italy.

PubMed

Insights

Mucin 1 (MUC1) expression correlates with chronic rhinosinusitis with nasal polyposis (CRSwNP) severity, particularly with eosinophils. This finding suggests MUC1 may serve as a valuable biomarker for CRSwNP.

Area of Science:

  • Immunohistochemistry and molecular pathology of respiratory diseases.
  • Cellular and molecular mechanisms of chronic inflammation in CRSwNP.

Background:

  • Mucins, especially MUC1, play a role in chronic respiratory disease pathogenesis.
  • Altered mucin expression in chronic rhinosinusitis with nasal polyposis (CRSwNP) may drive inflammation and tissue remodeling.
  • The specific role of MUC1 in CRSwNP and its link to disease severity remains unclear.

Purpose of the Study:

  • To evaluate MUC-1 expression in nasal polyps from CRSwNP patients.
  • To assess the correlation between MUC-1 expression and CRSwNP disease severity using the Clinical-Cytological Grading (CCG) system.

Main Methods:

  • Eighteen CRSwNP patients undergoing endoscopic sinus surgery (ESS) were studied.
  • Double-label immunofluorescence was used to detect MUC-1, CD15 (eosinophils), and Tryptase (mast cells).
  • Confocal microscopy quantified co-localization of MUC-1 with inflammatory cells (MUC-1+CD15+ and MUC-1+Tryptase+).

Main Results:

  • MUC1 was universally expressed in nasal polyps, with significantly increased levels correlating with higher CCG scores (p < 0.001).
  • Significant co-localization of MUC1 with CD15+ eosinophils was observed, increasing with disease severity (p < 0.001).
  • MUC1 co-localization with Tryptase+ mast cells was not significant, though both markers increased in severe CRSwNP (p < 0.001).

Conclusions:

  • A strong correlation exists between CRSwNP severity and MUC-1 expression, predominantly co-localized with eosinophils.
  • MUC-1 shows potential as a reliable biomarker for assessing CRSwNP severity.
  • Further research into MUC-1's role could inform targeted therapeutic strategies for CRSwNP.

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
609
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
456
Anatomy of Respiratory System I: Upper Respiratory Tract01:29

Anatomy of Respiratory System I: Upper Respiratory Tract

The upper respiratory tract plays a vital role in the respiratory system, comprising several structures that facilitate air intake and prepare air for the lungs. It also serves as the first line of defense against pathogens and particles. This tract includes the nose and nasal cavity, the oral cavity, the paranasal sinuses, and the pharynx, each with specific functions and features.
Nose and nasal cavity
The nose and nasal cavity represent the main external openings of the respiratory tract....
4.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.2K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
687